journal article·2019-03

Multifunctional nanoparticles based on a polymeric copper chelator for combination treatment of metastatic breast cancer

Ping Zhou, Jiaqi Qin, Ce Zhou, Guoyun Wan, Yuanyuan Liu, Mingming Zhang, Xiaoying Yang, Ning Zhang, Yinsong Wang

Biomaterials· Volume 195
Publisher page

Abstract

Copper plays an important role in tumor growth and metastasis. Copper chelation has been confirmed to be an effective strategy for breast cancer therapy through antiangiogenesis. In this work, a copper chelating coil-comb block copolymer RGD-PEG-b-PGA-g-(TETA-DTC-PHis) (RPTDH) was synthesized and used to prepare nanoparticles for loading resiquimod (R848), a TLR7 and TLR8 agonist, thus to combine antiangiogenesis and immune activation to treat breast cancer. RPTDH has strong copper-chelating ability and could self-assemble to form spherical nanoparticles with significant pH-sensitivity. R848 was efficiently loaded into RPTDH nanoparticles and exhibited greatly accelerated releases in weakly acid media simulating tumor microenvironment. RPTDH/R848 nanoparticles significantly inhibited the mobility, invasion and vascular tube formation of HUVECs via copper chelation, demonstrating their strong antiangiogenic activity in vitro. Furthermore, RPTDH/R848 nanoparticles remarkably induced the maturation and activation of human plasmacytoid dendritic CAL-1 cells, indicating their immune-activation ability. In breast tumor-bearing mice, RPTDH/R848 nanoparticles displayed excellent targeting ability for both primary breast tumor and lung metastases, and furthermore dramatically suppressed tumor growth and metastasis through copper deficiency-triggered antiangiogenesis and R848-induced immune activation. In summary, RPTDH/R848 nanoparticles can be used as an therapeutic agent against metastatic breast cancer through combining antiangiogenesis and immune activation.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Immune cells in cancer · Nanoplatforms for cancer theranostics · Cancer Immunotherapy and Biomarkers

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (46)

Show source-provided references
1. Breast cancer statistics, 201310.3322/caac.21203 ↗
2. Elevated copper and oxidative stress in cancer cells as a target for cancer treatment10.1016/j.ctrv.2008.07.004 ↗
3. Knockdown of copper chaperone antioxidant-1 by RNA interference inhibits copper-stimulated proliferation of non-small cell lung carcinoma cells10.3892/or.2013.2436 ↗
4. Endothelial cell phagokinesis in response to specific metal ions10.1016/0014-4827(80)90051-8 ↗
5. Copper stimulates proliferation of human endothelial cells under culture10.1002/(SICI)1097-4644(19980601)69:3<326::AID-JCB10>3.0.CO;2-A ↗
6. Role of copper in angiogenesis and its medicinal implications10.2174/092986709787846622 ↗
7. The role of copper in tumour angiogenesis10.1007/s10911-006-9003-7 ↗
8. Inhibition of human copper trafficking by a small molecule significantly attenuates cancer cell proliferation10.1038/nchem.2381 ↗
9. Reduced 64Cu uptake and tumor growth inhibition by knockdown of human copper transporter 1 in xenograft mouse model of prostate cancer10.2967/jnumed.113.126979 ↗
10. Role of the copper(II) complex Cu[15]pyN5 in intracellular ROS and breast cancer cell motility and invasion10.1111/cbdd.12521 ↗
11. Structural biology of copper trafficking10.1021/cr900104z ↗
12. Targeting copper in cancer therapy: 'Copper that Cancer10.1039/C5MT00149H ↗
13. Tetrathiomolybdate inhibits copper trafficking proteins through metal cluster formation10.1126/science.1179907 ↗
14. Targeting copper to treat breast cancer10.1126/science.349.6244.128 ↗
15. Treatment of Wilson disease with ammonium tetrathiomolybdate: III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy10.1001/archneur.60.3.379 ↗
16. Zinc and tetrathiomolybdate for the treatment of Wilson's disease and the potential efficacy of anticopper therapy in a wide variety of diseases10.1039/b901614g ↗
17. Anti-angiogenesis for cancer revisited: is there a role for combinations with immunotherapy?10.1007/s10456-017-9552-y ↗
18. Cancer immunotherapy: harnessing the immune system to battle cancer10.1172/JCI83871 ↗
19. Recent progress in therapeutic antibodies for cancer immunotherapy10.1016/j.cbpa.2018.05.006 ↗
20. Toll-like receptor 7/8 agonist, R848, exhibits antitumoral effects in a breast cancer model10.3892/mmr.2015.3885 ↗
21. Synthesis of a novel amphoteric chelating polymer flocculant and its performance in Cu2+ removal10.1002/app.37801 ↗
22. Delivery of copper-chelating trientine (TETA) to the central nervous system by surface modified liposomes10.1016/j.ijpharm.2016.08.040 ↗
23. Pharmacokinetic and pharmacodynamic modeling of a copper-selective chelator (TETA) in healthy adults10.1177/0091270009337939 ↗
24. pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery10.1016/j.biomaterials.2012.08.072 ↗
25. Synthesis of heterotelechelic poly(ethylene glycol) derivatives having α-benzaldehyde and ω-pyridyl disulfide groups by ring opening polymerization of ethylene oxide using 4-(diethoxymethyl)benzyl alkoxide as a novel initiator10.1021/bc0341775 ↗
26. pH-triggered reversible “stealth” polycationic micelles10.1021/bm701084w ↗
27. RGD-mediated delivery of small-molecule drugs10.4155/fmc-2017-0008 ↗
28. Smart superstructures with ultrahigh pH-sensitivity for targeting acidic tumor microenvironment: instantaneous size switching and improved tumor penetration10.1021/acsnano.6b02326 ↗
29. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway10.1038/ni758 ↗
30. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-84810.1038/ni0602-499 ↗
31. Competitive host-guest interaction between beta-cyclodextrin polymer and pyrene-labeled probes for fluorescence analyses10.1021/ac503301q ↗
32. Environmental effects on vibronic band intensities in pyrene monomer fluorescence and their application in studies of micellar systems10.1021/ja00449a004 ↗
33. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy10.1016/j.actbio.2017.11.010 ↗
34. Retention profile of Fe, Mn and Cu onto chemically treated polyurethane with carbon disulfide10.1080/03067319.2013.763249 ↗
35. pH-sensitive pullulan-based nanoparticle carrier of methotrexate and combretastatin A4 for the combination therapy against hepatocellular carcinoma10.1016/j.biomaterials.2013.05.081 ↗
36. S100A13 mediates the copper-dependent stress-induced release of IL-1alpha from both human U937 and murine NIH 3T3 cells10.1242/jcs.00471 ↗
37. IL-1alpha, IL-1beta and TNF-alpha secretion during in vivo/ex vivo cellular interactions with titanium and copper10.1016/S0142-9612(02)00359-9 ↗
38. Copper chelation represses the vascular response to injury10.1073/pnas.1231994100 ↗
39. Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis
40. Intratumoral CD3 and CD8 T-cell densities associated with relapse-free survival in HCC10.1158/2326-6066.CIR-15-0110 ↗
41. Toll-like receptor 7/8 agonist, R848, exhibits antitumoral effects in a breast cancer model10.3892/mmr.2015.3885 ↗
42. Priming CD8+ T cells with dendritic cells matured using TLR4 and TLR7/8 ligands together enhances generation of CD8+ T cells retaining CD2810.1182/blood-2010-11-317966 ↗
43. Kalra · Cancer Biol. Ther. · 2011 · 11 · 82610.4161/cbt.11.9.15183 ↗
44. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy10.1016/j.actbio.2017.11.010 ↗
45. Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients10.1093/annonc/mdu191 ↗
46. Immunoscore encompassing CD3+ and CD8+ T cell densities in distant metastasis is a robust prognostic marker for advanced colorectal cancer10.18632/oncotarget.13207 ↗